Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 5:16 pm Purchase | 2022-12-31 | 13G | VERASTEM, INC. VSTM | ORBIMED ADVISORS LLC | 1,375,270 7.900% | 1,375,270 (New Position) | Filing History |
| 2023-02-14 5:12 pm Purchase | 2022-12-31 | 13G | VECTIVBIO HLDG AG VECT | ORBIMED ADVISORS LLC | 6,713,561 10.700% | 1,810,057 (+36.91%) | Filing History |
| 2023-02-14 5:07 pm Sale | 2022-12-31 | 13G | THERAVANCE BIOPHARMA INC TBPH | ORBIMED ADVISORS LLC | 0 0.000% | -5,456,780 (Position Closed) | Filing History |
| 2023-02-14 5:04 pm Sale | 2022-12-31 | 13G | SONENDO INC SONX | ORBIMED ADVISORS LLC | 0 0.000% | -9,841 (Position Closed) | Filing History |
| 2023-02-14 4:59 pm Purchase | 2022-12-31 | 13G | SI-BONE INC SIBN | ORBIMED ADVISORS LLC | 3,201,100 9.300% | 3,201,100 (New Position) | Filing History |
| 2023-02-14 4:55 pm Sale | 2022-12-31 | 13G | RXSIGHT INC RXST | ORBIMED ADVISORS LLC | 923,733 3.300% | -138,767 (-13.06%) | Filing History |
| 2023-02-14 4:52 pm Unchanged | 2022-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 671,741 6.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:48 pm Unchanged | 2022-12-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.100% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:43 pm Purchase | 2022-12-31 | 13G | MERSANA THERAPEUTICS INC MRSN | ORBIMED ADVISORS LLC | 283,313 7.100% | 283,313 (New Position) | Filing History |
| 2023-02-14 4:40 pm Purchase | 2022-12-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | ORBIMED ADVISORS LLC | 10,378,591 5.920% | 4,315,246 (+71.17%) | Filing History |
| 2023-02-14 4:37 pm Sale | 2022-12-31 | 13G | MEIRAGTX HLDGS PLC MGTX | ORBIMED ADVISORS LLC | 0 0.000% | -3,593,966 (Position Closed) | Filing History |
| 2023-02-14 4:32 pm Purchase | 2022-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | ORBIMED ADVISORS LLC | 349,512 5.100% | 349,512 (New Position) | Filing History |
| 2023-02-14 4:30 pm Sale | 2022-12-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | ORBIMED ADVISORS LLC | 0 0.000% | -2,200,200 (Position Closed) | Filing History |
| 2023-02-14 4:25 pm Sale | 2022-12-31 | 13G | HARPOON THERAPEUTICS INC HARP | ORBIMED ADVISORS LLC | 80,421 2.400% | -86,369 (-51.78%) | Filing History |
| 2023-02-14 4:20 pm Unchanged | 2022-12-31 | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | ORBIMED ADVISORS LLC | 5,970,672 8.800% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:12 pm Unchanged | 2022-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | ORBIMED ADVISORS LLC | 3,196,876 5.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | CATALYST BIOSCIENCES INC N CBIO | ORBIMED ADVISORS LLC | 0 0.000% | -13,506 (Position Closed) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | APPLIED THERAPEUTICS INC APLT | ORBIMED ADVISORS LLC | 7,300,921 9.990% | 5,200,240 (+247.55%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | ALX ONCOLOGY HLDGS INC ALXO | ORBIMED ADVISORS LLC | 2,266,000 5.600% | 2,266,000 (New Position) | Filing History |
| 2023-02-14 4:01 pm Sale | 2022-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | ORBIMED ADVISORS LLC | 71,889 2.900% | -86,356 (-54.57%) | Filing History |